In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET

Panayotis K. Thanos, Nicholas B. Taintor, David Alexoff, Paul Vaska, Jean Logan, David Grandy, Yuan Fang, Jing Huei Lee, Joanna S. Fowler, Nora D. Volkow

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The use of mice with targeted gene deletions (knockouts [KOs]) provides an important tool to investigate the mechanisms underlying behavior, neuronal development, and the sequella of neuropsychiatric diseases. MRI has been used to image brain structural changes in KO mice but, to our knowledge, the feasibility of using PET to investigate brain neurochemistry in KO mice has not been demonstrated. Methods: We have evaluated the sensitivity of the microPET to image dopamine D2 receptor (DRD2) KO mice (D2-/-). PET measurements were performed in wild-type (D2+/+) mice and KO (D2-/-) mice using a microPET scanner. Briefly, each animal was anesthetized and injected intravenously with 11C-raclopride, a DRD2-specific ligand, and dynamic PET scanning was performed for 60 min. Results: The 11C-raclopride images of the KO mice showed significantly lower binding in the striatum (ST) than those of the wild-type (WT) mice, which was confirmed by the time-activity curves that revealed equivalent binding in the ST and cerebellum (CB) in KO mice, whereas the WT mice had significantly higher binding in the ST than in the CB. The ST/CB ratio was significantly higher in WT mice than in KO mice (ST/CB = 1.33 ± 0.13 and 1.05 ± 0.03, respectively; P <0.002; n = 10). The microPET images were compared qualitatively with conventional autoradiography images. Conclusion: These data support the use of microPET as an effective in vivo imaging tool for studying noninvasively KO mice. These same tools can be extended to investigate other genetically engineered murine models of disease. Future studies will seek to use microPET to investigate the relationships between genes, neuronal activity, and behavior.

Original languageEnglish (US)
Pages (from-to)1570-1577
Number of pages8
JournalJournal of Nuclear Medicine
Volume43
Issue number11
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Raclopride
Knockout Mice
Dopamine
Cerebellum
Neurochemistry
Gene Knockout Techniques
Dopamine D2 Receptors
Gene Deletion
Brain
Autoradiography
Ligands

Keywords

  • Animal model
  • Brain
  • Drug abuse
  • Gene therapy
  • Psychiatry

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Thanos, P. K., Taintor, N. B., Alexoff, D., Vaska, P., Logan, J., Grandy, D., ... Volkow, N. D. (2002). In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET. Journal of Nuclear Medicine, 43(11), 1570-1577.

In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET. / Thanos, Panayotis K.; Taintor, Nicholas B.; Alexoff, David; Vaska, Paul; Logan, Jean; Grandy, David; Fang, Yuan; Lee, Jing Huei; Fowler, Joanna S.; Volkow, Nora D.

In: Journal of Nuclear Medicine, Vol. 43, No. 11, 01.11.2002, p. 1570-1577.

Research output: Contribution to journalArticle

Thanos, PK, Taintor, NB, Alexoff, D, Vaska, P, Logan, J, Grandy, D, Fang, Y, Lee, JH, Fowler, JS & Volkow, ND 2002, 'In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET', Journal of Nuclear Medicine, vol. 43, no. 11, pp. 1570-1577.
Thanos PK, Taintor NB, Alexoff D, Vaska P, Logan J, Grandy D et al. In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET. Journal of Nuclear Medicine. 2002 Nov 1;43(11):1570-1577.
Thanos, Panayotis K. ; Taintor, Nicholas B. ; Alexoff, David ; Vaska, Paul ; Logan, Jean ; Grandy, David ; Fang, Yuan ; Lee, Jing Huei ; Fowler, Joanna S. ; Volkow, Nora D. / In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET. In: Journal of Nuclear Medicine. 2002 ; Vol. 43, No. 11. pp. 1570-1577.
@article{7d5d724b6ec946788beb77012d4e410f,
title = "In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET",
abstract = "The use of mice with targeted gene deletions (knockouts [KOs]) provides an important tool to investigate the mechanisms underlying behavior, neuronal development, and the sequella of neuropsychiatric diseases. MRI has been used to image brain structural changes in KO mice but, to our knowledge, the feasibility of using PET to investigate brain neurochemistry in KO mice has not been demonstrated. Methods: We have evaluated the sensitivity of the microPET to image dopamine D2 receptor (DRD2) KO mice (D2-/-). PET measurements were performed in wild-type (D2+/+) mice and KO (D2-/-) mice using a microPET scanner. Briefly, each animal was anesthetized and injected intravenously with 11C-raclopride, a DRD2-specific ligand, and dynamic PET scanning was performed for 60 min. Results: The 11C-raclopride images of the KO mice showed significantly lower binding in the striatum (ST) than those of the wild-type (WT) mice, which was confirmed by the time-activity curves that revealed equivalent binding in the ST and cerebellum (CB) in KO mice, whereas the WT mice had significantly higher binding in the ST than in the CB. The ST/CB ratio was significantly higher in WT mice than in KO mice (ST/CB = 1.33 ± 0.13 and 1.05 ± 0.03, respectively; P <0.002; n = 10). The microPET images were compared qualitatively with conventional autoradiography images. Conclusion: These data support the use of microPET as an effective in vivo imaging tool for studying noninvasively KO mice. These same tools can be extended to investigate other genetically engineered murine models of disease. Future studies will seek to use microPET to investigate the relationships between genes, neuronal activity, and behavior.",
keywords = "Animal model, Brain, Drug abuse, Gene therapy, Psychiatry",
author = "Thanos, {Panayotis K.} and Taintor, {Nicholas B.} and David Alexoff and Paul Vaska and Jean Logan and David Grandy and Yuan Fang and Lee, {Jing Huei} and Fowler, {Joanna S.} and Volkow, {Nora D.}",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "43",
pages = "1570--1577",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "11",

}

TY - JOUR

T1 - In vivo comparative imaging of dopamine D2 knockout and wild-type mice with 11C-raclopride and microPET

AU - Thanos, Panayotis K.

AU - Taintor, Nicholas B.

AU - Alexoff, David

AU - Vaska, Paul

AU - Logan, Jean

AU - Grandy, David

AU - Fang, Yuan

AU - Lee, Jing Huei

AU - Fowler, Joanna S.

AU - Volkow, Nora D.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The use of mice with targeted gene deletions (knockouts [KOs]) provides an important tool to investigate the mechanisms underlying behavior, neuronal development, and the sequella of neuropsychiatric diseases. MRI has been used to image brain structural changes in KO mice but, to our knowledge, the feasibility of using PET to investigate brain neurochemistry in KO mice has not been demonstrated. Methods: We have evaluated the sensitivity of the microPET to image dopamine D2 receptor (DRD2) KO mice (D2-/-). PET measurements were performed in wild-type (D2+/+) mice and KO (D2-/-) mice using a microPET scanner. Briefly, each animal was anesthetized and injected intravenously with 11C-raclopride, a DRD2-specific ligand, and dynamic PET scanning was performed for 60 min. Results: The 11C-raclopride images of the KO mice showed significantly lower binding in the striatum (ST) than those of the wild-type (WT) mice, which was confirmed by the time-activity curves that revealed equivalent binding in the ST and cerebellum (CB) in KO mice, whereas the WT mice had significantly higher binding in the ST than in the CB. The ST/CB ratio was significantly higher in WT mice than in KO mice (ST/CB = 1.33 ± 0.13 and 1.05 ± 0.03, respectively; P <0.002; n = 10). The microPET images were compared qualitatively with conventional autoradiography images. Conclusion: These data support the use of microPET as an effective in vivo imaging tool for studying noninvasively KO mice. These same tools can be extended to investigate other genetically engineered murine models of disease. Future studies will seek to use microPET to investigate the relationships between genes, neuronal activity, and behavior.

AB - The use of mice with targeted gene deletions (knockouts [KOs]) provides an important tool to investigate the mechanisms underlying behavior, neuronal development, and the sequella of neuropsychiatric diseases. MRI has been used to image brain structural changes in KO mice but, to our knowledge, the feasibility of using PET to investigate brain neurochemistry in KO mice has not been demonstrated. Methods: We have evaluated the sensitivity of the microPET to image dopamine D2 receptor (DRD2) KO mice (D2-/-). PET measurements were performed in wild-type (D2+/+) mice and KO (D2-/-) mice using a microPET scanner. Briefly, each animal was anesthetized and injected intravenously with 11C-raclopride, a DRD2-specific ligand, and dynamic PET scanning was performed for 60 min. Results: The 11C-raclopride images of the KO mice showed significantly lower binding in the striatum (ST) than those of the wild-type (WT) mice, which was confirmed by the time-activity curves that revealed equivalent binding in the ST and cerebellum (CB) in KO mice, whereas the WT mice had significantly higher binding in the ST than in the CB. The ST/CB ratio was significantly higher in WT mice than in KO mice (ST/CB = 1.33 ± 0.13 and 1.05 ± 0.03, respectively; P <0.002; n = 10). The microPET images were compared qualitatively with conventional autoradiography images. Conclusion: These data support the use of microPET as an effective in vivo imaging tool for studying noninvasively KO mice. These same tools can be extended to investigate other genetically engineered murine models of disease. Future studies will seek to use microPET to investigate the relationships between genes, neuronal activity, and behavior.

KW - Animal model

KW - Brain

KW - Drug abuse

KW - Gene therapy

KW - Psychiatry

UR - http://www.scopus.com/inward/record.url?scp=0036840163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840163&partnerID=8YFLogxK

M3 - Article

C2 - 12411561

AN - SCOPUS:0036840163

VL - 43

SP - 1570

EP - 1577

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -